Long-Acting -Agonists: Comparative Pharmacology and Clinical Outcomes

ISSN： 1175-6365

Source： American Journal of Respiratory Medicine, Vol.1, Iss.1, 2002-01, pp. : 55-74

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Management of Prolactinomas—Use of Long-Acting Dopamine Agonists

By Cook David

Reviews in Endocrine and Metabolic Disorders, Vol. 6, Iss. 1, 2005-01 ,pp. : 15-21

Springer Publishing Company

Access to resources Recommend Favorite

Combination Inhalers Containing Inhaled Corticosteroids and Long-Acting β 2 -Agonists: Improved Clinical Efficacy and Dosing Options in Patients with Asthma

By Ankerst Jaro

Journal of Asthma, Vol. 42, Iss. 9, 2005-10 ,pp. : 715-724

Informa Healthcare

Access to resources Recommend Favorite

Long-Acting Beta-Agonists and the Risk of Intensive Care Unit Admission in Children

By Jacobs Tammy S. Jones Bobby L. MacGinnitie Andrew J.

Journal of Asthma, Vol. 49, Iss. 5, 2012-06 ,pp. : 450-455

Informa Healthcare

Access to resources Recommend Favorite

Combination Therapy of Long-Acting  2 -Adrenoceptor Agonists and Corticosteroids for Asthma

By Chung K. Fan

Treatments in Respiratory Medicine, Vol. 3, Iss. 5, 2004-01 ,pp. : 279-289

Adis International

Access to resources Recommend Favorite

Asthma Mortality and Long-Acting Beta2-Agonists in Five Major European Countries, 1994-2004

By Chatenoud Liliane Malvezzi Matteo Pitrelli Andrea La Vecchia Carlo Bamfi Francesco

Journal of Asthma, Vol. 46, Iss. 6, 2009-08 ,pp. : 546-551

Informa Healthcare

Access to resources Recommend Favorite